After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...
23h
Amgen Calls 2026 a “Springboard Year” as CEO Flags Major Data, MariTide Phase 3 Push at JPM Event
Chief Executive Officer Bob Bradway told attendees at a J.P. Morgan-hosted event that the company views 2026 as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback